Pfizer's Kristofco comments on outcomes-oriented CME

Share this article:

During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma “continues to have an expectation for more outcomes-oriented CME,” and that he expects grants from public and private sources will “begin to assess the current climate for [CPD].”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.